Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trialDiwakar Davar, Janis M. Taube, Robert M. Morrison et al.|Cancer Cell|2024Cited by 60
Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced MelanomaYana G. Najjar, Ahmad A. Tarhini, Dustin McCurry et al.|Clinical Cancer Research|2021Cited by 26
Abstract 1946: Identification of miRNAs that contribute to melanoma brain metastasisAvital Gaziel, Eva Hernando, Sílvia Menéndez et al.|Cancer Research|2010Cited by 2
Phase IB study of pembrolizumab (Pembro) and pegylated-interferon alfa-2b (Peg-IFN) in advanced melanoma (MEL).Diwakar Davar, Giuseppe Lo Russo, Julien Fourcade et al.|Journal of Clinical Oncology|2016Cited by 2